2014 Volume 77 Issue 5 Pages 398
Waon therapy has been developed by Prof Tei, and currently been approved as one of advanced medical care in Japanese governmental insurance system since 2013. We are now conducting a multicenter randomized study for the establishment of efficacy and safety of Waon therapy. As one of institutes participating in the multicenter trial, I will present data from our hospital for the efficacy and safety issues of Waon therapy. We preliminarily observed that Waon therapy reduced heart rate and cardiothoracic ratio with significant improvement of 6 minutes’ walk distance. No serious adverse event was observed. Once the study concludes, we hope that Waon therapy can be reimbursed by insurance.